Patent · US Expired

N,N,N',N'-6-(1-piperazinyl)-2,5-pyridinediamines

US5202316A · kind A · utility

25Cited by
4References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 9, 1991
Grant dateApr 13, 1993
Priority date
Expiry dateOct 9, 2011

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J43/003
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound selected from the group consisting of a compound of the formula ##STR1## wherein R.sub.A, R'.sub.A, R.sub.B and R'.sub.B are individually selected from the group consisting of hydrogen and alkyl of 1 to 4 carbon atoms or R.sub.A and R'.sub.A or R.sub.B and R'.sub.B together with the nitrogen atom to which they are attached form a 5- to 6-member heterocycle optionally substituted with alkyl of 1 to 3 carbon atoms and Y is hydrogen or ##STR2## wherein R.sub.6 is selected from the group consisting of hydrogen, --CH.sub.3, --F and --Cl, R.sub.9 and R.sub.11 form a second bond at 9(11) or R.sub.9 is hydrogen or --F is hydrogen, --OH or .dbd.O, R.sub.16 is --CH.sub.3 or hydrogen, R.sub.17 is hydrogen, --OH or acyloxy, the dotted lines indicate the possible presence of a second bond at 1(2) and 6(7)-positions and the wavy line indicates the .alpha.- and .beta.-position and their non-toxic, pharmaceutically acceptable acid addition salts having anti-inflammatory and antioxidant activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.